WallStreetZenWallStreetZen

NYSE: BSX
Boston Scientific Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BSX

Based on 20 analysts offering 12 month price targets for Boston Scientific Corp

Min Forecast
$71.00+18.43%
Avg Forecast
$89.85+49.87%
Max Forecast
$118.00+96.83%

Should I buy or sell BSX stock?

Based on 20 analysts offering ratings for Boston Scientific Corp.

Strong Buy
Strong Buy
13 analysts 65%
Buy
7 analysts 35%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BSX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BSX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BSX stock forecasts and price targets.

BSX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-23
Truist Securities
Top 16%
85
Strong BuyMaintains$85.00+41.78%2026-04-23
Baird
Top 21%
80
BuyMaintains$78.00+30.11%2026-04-23
Goldman Sachs
Bottom 8%
8
Strong BuyMaintains$84.00+40.12%2026-04-23
Needham
Top 31%
70
BuyMaintains$77.00+28.44%2026-04-23
Jefferies
Top 17%
84
Strong BuyMaintains$100.00+66.81%2026-04-22

1 of 2

Forecast return on equity

Is BSX forecast to generate an efficient return?

Company
30.3%
Industry
29.52%
Market
172.91%
BSX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BSX forecast to generate an efficient return on assets?

Company
16.82%
Industry
15.11%
BSX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BSX earnings per share forecast

What is BSX's earnings per share in the next 3 years based on estimates from 37 analysts?

Avg 1 year Forecast
$3.49+77.91%
Avg 2 year Forecast
$3.95+101.4%
Avg 3 year Forecast
$4.44+126.66%
BSX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BSX revenue forecast

What is BSX's revenue in the next 3 years based on estimates from 37 analysts?

Avg 1 year Forecast
$22.5B+11.85%
Avg 2 year Forecast
$24.7B+23.21%
Avg 3 year Forecast
$27.2B+35.46%
BSX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BSX earnings growth forecast

How is BSX forecast to perform vs Medical Devices companies and vs the US market?

Company
31.28%
Industry
23.87%
Market
35.62%
BSX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BSX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BSX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BSX revenue growth forecast

How is BSX forecast to perform vs Medical Devices companies and vs the US market?

Company
10.59%
Industry
9.15%
Market
14.35%
BSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BSX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BSX$59.95$89.85+49.87%Strong Buy
MDT$82.92$108.41+30.74%Buy
SYK$329.01$408.09+24.04%Buy
EW$83.46$97.41+16.72%Strong Buy
PHG$27.54N/AN/A
View Top Medical Device Stocks

Boston Scientific Stock Forecast FAQ

Is Boston Scientific Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 20 Wall Street analysts covering (NYSE: BSX) stock is to Strong Buy BSX stock.

Out of 20 analysts, 13 (65%) are recommending BSX as a Strong Buy, 7 (35%) are recommending BSX as a Buy, 0 (0%) are recommending BSX as a Hold, 0 (0%) are recommending BSX as a Sell, and 0 (0%) are recommending BSX as a Strong Sell.

If you're new to stock investing, here's how to buy Boston Scientific stock.

What is BSX's earnings growth forecast for 2026-2028?

(NYSE: BSX) Boston Scientific's forecast annual earnings growth rate of 31.28% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.

Boston Scientific's earnings in 2026 is $2,898,000,000.On average, 37 Wall Street analysts forecast BSX's earnings for 2026 to be $5,174,456,974, with the lowest BSX earnings forecast at $4,971,906,609, and the highest BSX earnings forecast at $5,437,698,254. On average, 37 Wall Street analysts forecast BSX's earnings for 2027 to be $5,857,489,449, with the lowest BSX earnings forecast at $5,496,905,283, and the highest BSX earnings forecast at $6,310,222,902.

In 2028, BSX is forecast to generate $6,592,161,138 in earnings, with the lowest earnings forecast at $5,816,830,988 and the highest earnings forecast at $7,104,843,563.

What is BSX's revenue growth forecast for 2026-2028?

(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 10.59% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.35%.

Boston Scientific's revenue in 2026 is $20,074,000,000.On average, 37 Wall Street analysts forecast BSX's revenue for 2026 to be $33,316,196,258,112, with the lowest BSX revenue forecast at $31,928,763,356,752, and the highest BSX revenue forecast at $35,395,119,781,968. On average, 37 Wall Street analysts forecast BSX's revenue for 2027 to be $36,700,938,983,248, with the lowest BSX revenue forecast at $34,939,566,946,976, and the highest BSX revenue forecast at $39,187,931,007,504.

In 2028, BSX is forecast to generate $40,351,297,205,008 in revenue, with the lowest revenue forecast at $38,083,920,228,240 and the highest revenue forecast at $42,836,805,343,808.

What is BSX's forecast return on assets (ROA) for 2026-2029?

(NYSE: BSX) forecast ROA is 16.82%, which is higher than the forecast US Medical Devices industry average of 15.11%.

What is BSX's Price Target?

According to 20 Wall Street analysts that have issued a 1 year BSX price target, the average BSX price target is $89.85, with the highest BSX stock price forecast at $118.00 and the lowest BSX stock price forecast at $71.00.

On average, Wall Street analysts predict that Boston Scientific's share price could reach $89.85 by Apr 23, 2027. The average Boston Scientific stock price prediction forecasts a potential upside of 49.87% from the current BSX share price of $59.95.

What is BSX's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: BSX) Boston Scientific's current Earnings Per Share (EPS) is $1.96. On average, analysts forecast that BSX's EPS will be $3.49 for 2026, with the lowest EPS forecast at $3.35, and the highest EPS forecast at $3.66. On average, analysts forecast that BSX's EPS will be $3.95 for 2027, with the lowest EPS forecast at $3.70, and the highest EPS forecast at $4.25. In 2028, BSX's EPS is forecast to hit $4.44 (min: $3.92, max: $4.79).

What is BSX's forecast return on equity (ROE) for 2026-2029?

(NYSE: BSX) forecast ROE is 30.3%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.